AQR had a good piece on EM allocations, pushing for a much larger SAA weight to the region.
Basic idea is that EM is cheap,
& has a lowish correl to other markets, and equity market vol has declined.
Equally, in our view, it’s also had one of the weaker EPS outcomes, out of all other possible markets.
And is ill-suited to outperform, economically, or otherwise, in a world in which financial conditions are tightening. The below just breaks down eps vs total return vs currency impact.
We are late cycle, with regard to rate hikes. Either inflation is tamed successfully, and rates fall back (soft landing) or tamed unsuccessfully, through recession (and obviously the last possibility is untamed, inflation stays higher, as do rates).
You might say “well, Dave, you’ve got the odds of a soft landing at 60% or so, hence, why not a little more EM if your base case is victory”.
And it is a good point. The portfolio is full of compromise, like an awkwardly fitting suit. The left tail outcomes for EM seem much larger than for the developed world.
So, the exposures we do have, boring perhaps though they may be, reflect that (in our view) more favourable sequencing risk.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.